[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100561903":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":7,"responsibleParty":18,"collaborators":7,"id":22,"slug":23,"hasResults":24,"nctId":25,"briefTitle":26,"officialTitle":27,"acronym":7,"eligibilityCriteria":28,"healthyVolunteers":24,"sex":29,"minAge":30,"maxAge":7,"enrollmentInfo":31,"targetDuration":7,"studyType":34,"phases":7,"briefSummary":35,"conditions":36,"keywords":7,"overallStatus":39,"whyStopped":7,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":7},{"fullName":5,"class":6},"Chinese University of Hong Kong","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Angel Chim, MSc","CONTACT","852-35053759","angelchim@cuhk.edu.hk",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},"Grace Wong, MD","852-35054205","wonglaihung@cuhk.edu.hk",{"type":19,"investigatorFullName":20,"investigatorTitle":21,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Grace Lai Hung Wong","Professor","100561903","hepatitis-inequalities-study-100561903",false,"NCT06596213","Hepatitis Inequalities Study","Overcoming Inequalities in Health to Eliminate Hepatitis - Real-World Evidence from a Territory-Wide Cohort","Inclusion Criteria:\n\n* Patients will be eligible if they have any of these viral markers (HBeAg \u002F HBsAg \u002F HBV DNA \u002F HCV RNA) and\u002For any of the following diagnosis codes (ICD-9 070-070.9; 348.3, 349.82, 456, 456.2, 456.8, 567.2, 567.8, 570, 571.2, 571.5, 571.6, 572.2, 572.3, 572.4, 789.5) checked or coded in any public hospitals or clinics from 1 January 2000 to 31 March 2024.\n\nExclusion Criteria:\n\n* Patients with missing age, gender, ethnicity and socioeconomic status\n* (Subgroup analysis for ethnicity and socioeconomic status) Patients with missing ethnicity and socioeconomic status\n* Serious medical illnesses or malignancy with life expectancy \\<1 year","ALL","18 Years",{"count":32,"type":33},100000,"ESTIMATED","OBSERVATIONAL","Health inequality in liver diseases including age, gender, ethnicity and socioeconomic status has been increasingly recognised and potentially hinder hepatitis elimination. Health inequality has significant impact to evaluate the impact diagnostic and treatment uptake rates of chronic viral hepatitis on risk of hepatocellular carcinoma (HCC), hepatic event and liver-related death in patients with chronic hepatitis B and\u002For C. To overcome the limitation of small prospective cohort study of limited recruitment period, retrieving information from the Clinical Data Analysis and Reporting System (CDARS) from Hospital Authority (HA) will be one of the best way to answer these questions.",[37,38],"Chronic Hepatitis B","HEPATITIS C VIRUS CHRONIC INFECTION","NOT_YET_RECRUITING","2024-09-16",{"date":42,"type":43},"2024-09-19","ACTUAL",{"date":45,"type":33},"2024-10-01",{"date":47,"type":33},"2031-06-30",{"name":5,"class":6}]